Essential Pharma progress in its ESG performance

The company now exceeds the sector benchmark for its overall ESG rating and for all three measures

Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries

Medicines, including insulin, to be available in 40 lower-income countries

DTx Pharma appoints Peter Condon as Chief Business Officer

Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.

GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer

Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics

Sanofi India appoints Preeti Futnani as GM, Vaccines

Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.

Ovensa and Celanese to collaborate to advance precision drug delivery

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies

Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases

Global pharma back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas

Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule

GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology

Novartis announces new organizational structure

New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity